Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor. (Q40850663)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor. |
scientific article |
Statements
Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor (English)
Annunziata CM
Safiran YJ
Irving SG
Kasid UN